Emerging therapies for cerebrovascular disorders

Stroke

Volumn 36, Issue 2, 2005, Pages 208-210

  Davalos, Antoni ^a   Fisher, Marc ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Advances in Stroke; Intracerebral hemorrhage; Stroke prevention; Stroke, acute

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DESMOTEPLASE; PLACEBO; PROUROKINASE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTERY PERFORATION; BRAIN HEMORRHAGE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; DEATH; FOOD AND DRUG ADMINISTRATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MONOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; RANKIN SCALE; RECANALIZATION; REVIEW; RISK BENEFIT ANALYSIS; STROKE; SYSTEMATIC REVIEW;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; DRUG APPROVAL; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 12844282834     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000153062.32426.f6     Document Type: Review

References (14)

1. Broderick JP, Adams HP, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905-915.
2. Mendelow AD. International Surgical Trial in Intracerebral Hemorrage (ISTICH): a randomized trial of a policy of "early surgery" compared with a policy of "initial conservative treatment" in patients with spontaneous supratentorial intracerebral hemorrhage. Lancet 2005; In press.
3. Gregson BA, Mendelow AD; STICH Investigators. International variations in surgical practice for spontaneous intracerebral hemorrhage. Stroke. 2003;34:2593-2598.
4. Mayer S. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke. 2003;34:224-229.
5. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees K, Soehngen M, Warach S; DIAS Study Group. The Desmoteplase In Acute Ischemic Stroke Trial (DIAS). A phase II MRI-based nine-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
6. US Food and Drug Administration. FDA's Mission Statement. Available at http://www.fda.gov/opacom/morechoices/mission.html. Accessed December 22, 2004.
7. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. J Am Med Assoc. 1999;282:2003-2011.
8. North American Symptomatic Carotid Endartererctomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:445-453.
9. Barnett HJM, Taylor DW, Eliasziw M. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe carotid stenosis. N Engl J Med. 1998;339:1413-1425.
10. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. J Am Med Assoc. 1995;273:1421-1428.
11. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 2004;363:1491-1501.
12. Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic stenosis: Asymptomatic Carotid Surgery Trial. Stroke. 2004;35:2425-2427.
13. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Balwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K; Stenting and Angioplasty with Protection at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
14. Diener H-C, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprect H-J; MATCH Investigators. Aspirin and Clopidogrel compared with Clopidogrel alone after recent ischaemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind placebo-controlled trial. Lancet. 2004;364:331-337.